NextCure (NASDAQ:NXTC – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a report released on Friday, Benzinga reports. They currently have a $8.00 price target on the stock. HC Wainwright’s target price would suggest a potential upside of 422.88% from the company’s previous close. Separately, Needham & […]
Marquette Asset Management LLC acquired a new stake in shares of NextCure, Inc. (NASDAQ:NXTC – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm acquired 58,259 shares of the company’s stock, valued at approximately $66,000. Separately, Acuitas Investments LLC raised its holdings in NextCure by 30.0% during the 4th quarter. Acuitas Investments LLC […]
NextCure, Inc. (NASDAQ:NXTC – Get Free Report) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 839,700 shares, a growth of 579.9% from the February 29th total of 123,500 shares. Based on an average trading volume of 229,500 shares, the short-interest ratio is […]
NextCure, Inc. (NASDAQ:NXTC – Get Free Report) was the target of a significant decrease in short interest during the month of January. As of January 31st, there was short interest totalling 108,900 shares, a decrease of 11.8% from the January 15th total of 123,400 shares. Based on an average daily volume of 91,000 shares, the […]
NextCure, Inc. (NASDAQ:NXTC – Get Free Report)’s stock price dropped 1.1% during trading on Monday . The stock traded as low as $1.30 and last traded at $1.34. Approximately 117,807 shares traded hands during trading, an increase of 79% from the average daily volume of 65,754 shares. The stock had previously closed at $1.35. NextCure […]